Kazuo Oda

YM753, a novel histone deacetylase inhibitor, exhibits antitumor activity with selective, sustained accumulation of acetylated histones in tumors in the WiDr xenograft model

Nobuaki Shindoh, Masamichi Mori, Yoh Terada et al. · International Journal of Oncology · 2008 · 40 citations · Full text

Histone Modifications, Hdac Inhibitors, Antitumor Activity +17

Effects of aripiprazole and its active metabolite dehydroaripiprazole on the activities of drug efflux transporters expressed both in the intestine and at the blood–brain barrier

Yasuhisa Nagasaka, Kazuo Oda, Takafumi Iwatsubo et al. · Biopharmaceutics & Drug Disposition · 2012 · 25 citations

Drug Efflux Transporters, Gastrointestinal Pharmacology, Inhibition Potencies +19

Human mass balance, metabolite profile and identification of metabolic enzymes of [¹⁴C]ASP015K, a novel oral janus kinase inhibitor

Kazuo Oda, Ying Cao, Taiji Sawamoto et al. · Xenobiotica · 2015 · 23 citations

Metabolomic Profiling, Physiologically-based Pharmacokinetic Modeling, Metabolite Profile +23

Identification and characterization of metabolites of ASP015K, a novel oral Janus kinase inhibitor, in rats, chimeric mice with humanized liver, and humans

Naoyuki Nakada, Kazuo Oda · Xenobiotica · 2015 · 17 citations

Chemoprevention Strategy, Metabolomic Profiling, Chimeric Mice +19

A drug–drug interaction study to evaluate the impact of peficitinib on OCT1- and MATE1-mediated transport of metformin in healthy volunteers

Mai Shibata, Junko Toyoshima, Yuichiro Kaneko et al. · European Journal of Clinical Pharmacology · 2020 · 16 citations · Full text